The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Open accessAbstract
Liver cirrhosis is a very complex disease in which several pathological processes such as inflammation, fibrosis, and pathological angiogenesis are closely integrated. We hypothesized that treatment with pharmacological agents with multiple mechanisms of action will produce superior results to those achieved by only targeting individual mechanisms. This study thus evaluates the therapeutic use of the multitargeted receptor tyrosine kinase inhibitor Sunitinib (SU11248). The in vitro effects of SU11248 were evaluated in the human hepatic stellate cell line LX-2 by measuring cell viability. The in vivo effects of SU11248 treatment were monitored in the livers of cirrhotic rats by measuring angiogenesis, inflammatory infiltrate, fibrosis, α-smooth muscle actin (α-SMA) accumulation, differential gene expression by microarrays, and portal pressure. Cirrhosis progression was associated with a significant enhancement of vascular density and expression of vascular endothelial growth factor-A, angiopoietin-1, angiopoietin-2, and placental growth factor in cirrhotic livers. The newly formed hepatic vasculature expressed vascular cellular adhesion molecule 1 and intercellular adhesion molecule 1. Interestingly, the expression of these adhesion molecules was adjacent to areas of local inflammatory infiltration. SU11248 treatment resulted in a significant decrease in hepatic vascular density, inflammatory infiltrate, α-SMA abundance, LX-2 viability, collagen expression, and portal pressure. Conclusion: These results suggest that multitargeted therapies against angiogenesis, inflammation, and fibrosis merit consideration in the treatment of cirrhosis. (Hepatology 2007.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Self-citationMolecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,080
Self-citationEndothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,039
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2005) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,014
Self-citationThe codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 694
Abrams, T. J., Lee, L. B., Murray, L. J., Pryer, N., & Cherrington, J. M. (2003) · PubMed · Cited by 685
Pinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 478
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D. J., Wu, Y., Yanase, K., Namisaki, T., Yamazaki, M., et al. (2003) · Gut · doi:10.1136/gut.52.9.1347 · Cited by 307
Wong, L., Yamasaki, G., Johnson, R. J., & Friedman, S. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117497 · Cited by 304
Self-citationArteel, G., Thurman, R., Yates, J., & Raleigh, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.429 · Cited by 295
Active participation of endothelial cells in inflammation
Cook-Mills, J. M., & Deem, T. L. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904554 · Cited by 282
Fernandez, M., Vizzutti, F., Garcia-Pagan, J. C., Rodes, J., & Bosch, J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.012 · Cited by 259
Kukielka, G. L., Hawkins, H. K., Michael, L., Manning, A. M., Youker, K., Lane, C., Entman, M. L., Smith, C. W., & Anderson, D. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116729 · Cited by 229
Fernandez, M., Mejias, M., Angermayr, B., Garcia-Pagan, J. C., Rodés, J., & Bosch, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.022 · Cited by 217
Self-citationINTRARENAL OXYGENATION IN CHRONIC RENAL FAILURE
Norman, J. T., & Fine, L. G. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04476.x · Cited by 154
The scarring of the liver acini (Cirrhosis)
Rappaport, A. M., MacPhee, P. J., Fisher, M. M., et al. (1983) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00695054 · Cited by 141
Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats
Morales‐Ruiz, M., Cejudo–Martín, P., Fernández‐Varo, G., Tugues, S., Ros, J., Angeli, P., Rivera, F., Arroyo, V., Rodés, J., Sessa, W. C., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00909-0 · Cited by 128
Self-citationHepatic fibrosis as wound repair: A progress report
Bissell, D. M. (1998) · Journal of Gastroenterology · doi:10.1007/s005350050087 · Cited by 120
Osawa, Y., Nagaki, M., Banno, Y., Brenner, D. A., Asano, T., Nozawa, Y., Moriwaki, H., & Nakashima, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6294-6301.2002 · Cited by 108
Emerging Roles of Targeted Small Molecule Protein-Tyrosine Kinase Inhibitors in Cancer Therapy
Smith, J. K., Mamoon, N. M., & Duhé, R. J. (2003) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000003772462298 · Cited by 96
Wang, Y. Q., Ikeda, K., Ikebe, T., Hirakawa, K., Sowa, M., Nakatani, K., Kawada, N., & Kaneda, K. (2000) · Hepatology · doi:10.1053/jhep.2000.18658 · Cited by 74
Deeks, E. D., & Keating, G. M. (2006) · Drugs · doi:10.2165/00003495-200666170-00007 · Cited by 64
Microarray Analysis of Endothelial Differentially Expressed Genes in Liver of Cirrhotic Rats
Tugues, S., Morales‐Ruiz, M., Fernández‐Varo, G., Ros, J., Arteta, D., Muñoz, J., Arroyo, V., Rodés, J., & Jiménez, W. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.006 · Cited by 46
Self-citationRos, J., Leivas, A., Jiménez, W., Morales‐Ruiz, M., Bosch‐Marcé, M., Arroyo, V., Rivera, F., & Rodés, J. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80013-x · Cited by 43
Self-citationNeovascularization, Angiogenesis, and Vascular Remodeling in Portal Hypertension
Morales‐Ruiz, M., & Jiménez, W. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-885-4_7 · Cited by 19
Self-citation
Cited by
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationHepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Self-citationCainap, C., Qin, S., Huang, W.-T., Chung, I. J., Pan, H., Cheng, Y., Kudo, M., Kang, Y.-K., Chen, P.-J., Toh, H.-C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.3298 · Cited by 629
Fernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
Evolving therapies for liver fibrosis
Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 595
Metadata
- Authors
- Tugues, S., Fernandez-Varo, G., Muñoz-Luque, J., Ros, J., Arroyo, V., Rodés, J., Friedman, S. L., Carmeliet, P., Jiménez, W., & Morales-Ruiz, M.
- Venue
- Hepatology
- Published
- 2007-12
- Volume
- 46
- Issue
- 6
- Pages
- 1919-1926
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2071679347
- Cited by
- 261
- References
- 29
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.